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What are the novel findings of this work? 
There are no consistent data on the outcome of TTTS in monochorionic monoamniotic twin 
pregnancies. Moreover, it is not clear whether treatments may be preferable in term of perinatal 
survival, when managing TTTS in monoamniotic twins. 
 
What are the clinical implications of this work? 
The aim of this study was to explore the outcome of monochorionic monoamniotic twin 
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ABSTRACT  
Objectives: To explore the outcome of monochorionic monoamniotic (MCMA) twin pregnancies 
affected by twin-to-twin transfusion syndrome (TTTS). 
Methods: Medline and Embase databases were searched. The primary outcome was intra-uterine 
death (IUD); secondary outcomes were: miscarriage, single IUD, double IUD, neonatal death 
(NND), perinatal death (PND), presence of at least one or both survivors and preterm birth (PTB) 
<32 weeks of gestation. All these outcomes were assessed in MCMA twins affected by TTTS not 
undergoing intervention and in those treated with amniodrainage, laser therapy and cord occlusion. 
Sub-group analysis including cases diagnosed <24 weeks of gestation was also performed. 
Random-effect meta-analyses of proportions were used to analyze the data.  
Results: Seventeen retrospective cohort studies (890 MCMA twin pregnancies, 46 affected by 
TTTS) were included in the review while there was no randomised trial comparing the different 
management options in MCMA twin pregnancies complicated by TTTS. In cases not undergoing 
intervention, miscarriage occurred in 10.7% of fetuses, while the incidence of IUD, NND and PND 
was 24.3%, 13.5%  and 32.4% respectively. PTB complicated 54.0% of these pregnancies. In cases 
treated by laser surgery, the incidence of miscarriage, IUD, NND and PND was 19.6%, 27.4%, 
7.4% and 35.9% respectively. The incidence of PTB <32 weeks of gestation was 64.9%. In cases 
treated with amniodrainage, the incidence of IUD, NND and PND was 30.3%, 19.1% and 35.9% 
respectively. PTB complicated 78.1% of cases. Analysis of cases undergoing cord occlusion was 
affected by the very small number of included cases. Miscarriage occurred in 19.2%, while there 
was no IUD or NND of the surviving twin. PTB <32 weeks occurred in 50.0% of cases. 
Conclusion: MCMA twin pregnancies complicated by TTTS are at high risk of perinatal mortality 
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INTRODUCTION  
Twin to twin transfusion syndrome (TTTS) is one of the most severe complications of 
monochorionic twin pregnancies, with an estimated incidence of 9-15%
1
. Although the 
pathophysiology of TTTS has not been fully elucidated yet, the anatomical prerequisite for its 
occurrence is the presence of inter-twin vascular anastomoses within the placenta which are 
virtually present in every MC gestation
2
. TTTS is associated with a high risk of perinatal mortality 
and morbidity if not treated. The introduction of laser therapy of placental anastomoses in clinical 
practice has led to a significant reduction in perinatal mortality of the multiple pregnancies 
complicated by TTTS, especially in monochorionic diamniotic (MCDA) twin pregnancies.  
Monochorionic monoamniotic (MCMA) twin pregnancies are at higher risk of perinatal mortality 
and morbidity compared to MCDA gestations. The overall incidence of fetal loss in MCA twin 
pregnancies is approximately 6%, with the large majority of losses them occurring before 30 weeks 
of gestation
2
. TTTS can also occur in MCMA twin pregnancies; although its incidence has been 
reported to be 2.4 to 2.7 times lower than in MCDA twin gestations
2
. The lower incidence of TTTS 
in MCMA pregnancies likely reflects the different anastomotic pattern observed in MA gestations, 
with a higher prevalence of arterio-arterial anastomoses which are protective against the occurrence 
of this pathology
3-5
. Despite its importance, there is no consistent data on the outcome of TTTS in 
MCMA twin pregnancies. Furthermore, the role of laser therapy in MCMA pregnancies affected by 
TTTS has not been fully established. Moreover, it is not clear whether other treatments (i.e. cord 
occlusion) may be preferable in terms of perinatal survival, when managing TTTS in MCMA twins. 
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METHODS  
Protocol, information sources and literature search  
This review was performed according to an a-priori designed protocol and recommended for 
systematic reviews and meta-analysis
6
. Medline and Embase databases were searched electronically 
on the 10
th
 January 2019 utilizing combinations of the relevant medical subject heading (MeSH) 
terms, key words, and word variants for “twin to twin transfusion syndrome”, “monoamniotic 
pregnancies”, “ultrasound” and “outcome”. The search and selection criteria were restricted to 
English language. Reference lists of relevant articles and reviews were hand searched for additional 
reports. Prisma guidelines were followed
7
.  The study was registered with the PROSPERO database 
(Registration number: CRD42016043062).  
  
Outcomes’ measures, study selection and data collection  
The primary outcome was intra-uterine death (IUD) defined as the death of either twin 20 weeks 
of gestation. 
Secondary outcomes were: 
 Miscarriage, defined as the loss of either twin prior to 20 weeks of gestation  
 Single IUD, defined as the loss of a twin  20 weeks of gestation  
 Double IUD, defined as the loss of both twins  20 weeks of gestation 
 Neonatal death (NND), defined as the death of either twin up to 28 days after birth 
 Perinatal death (PND), defined as the sum of IUD and NND  
 Rate of survivors, defined as the percentage of twins not affected by PND or miscarriage 
 Presence of at least one survivor 
 Presence of both survivors 
 Preterm birth (PTB) <32 weeks of gestation 
 
All the explored outcomes were reported for MCMA twins not undergoing intervention, for those 
treated with laser therapy, amniodrainage and cord occlusion respectively. For the purpose of the 
analysis, single and double IUD, NND, PND and survivors, were not computed in the group of 
twins undergoing cord occlusion. Since the hydramnios-oligohydramnios sequence cannot be 
detected in monoamniotic pregnancies, diagnosis of twin–twin transfusion syndrome was based on 
the identification of other clinical manifestations of the syndrome, such as polyhydramnios (deepest 
vertical pocket 8 or more cm before 20 weeks of gestation or 10 or more cm after 20 weeks of 
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recipient), and abnormal Doppler flow patterns in either twin. Furthermore, we planned a sub-group 
analysis considering only cases affected by TTTS diagnosed  24 weeks of gestation.  
 
Only studies reporting the outcome of MCMA twin pregnancies affected by TTTS were considered 
suitable for the inclusion in the current systematic review. Studies including higher order multiple 
gestations, those including cases of iatrogenic MCMA twin pregnancies, structural or chromosomal 
anomalies and those from which data on amnionicity could not be extrapolated were excluded. 
Studies published before 2000 were also excluded, as we considered that advances in prenatal 
imaging techniques, improvements in the diagnosis and treatment of TTTS make them less relevant. 
Only full text articles were considered eligible for the inclusion; case reports and conference 
abstracts were also excluded in order to avoid publication bias.  
Two authors (DM, DB) reviewed all abstracts independently. Agreement regarding potential 
relevance was reached by consensus. Full text copies of those papers were obtained, and the same 
two reviewers independently extracted relevant data regarding study characteristics and pregnancy 
outcome. Inconsistencies were discussed by the reviewers and consensus reached or by discussion 
with a third author. If more than one study was published for the same cohort with identical 
endpoints, the report containing the most comprehensive information on the population was 
included to avoid overlapping populations. For those articles in which information was not reported 
but the methodology was such that this information would have been recorded initially, the authors 
were contacted.  
 
Quality assessment, risk of bias and statistical analysis 
Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale (NOS) 
for cohort studies. According to NOS, each study is judged on three broad perspectives: the 
selection of the study groups; the comparability of the groups; and the ascertainment of the outcome 
of interest
8
. Assessment of the selection of a study includes the evaluation of the representativeness 
of the exposed cohort, selection of the non-exposed cohort, ascertainment of exposure and the 
demonstration that the outcome of interest was not present at start of study. Assessment of the 
comparability of the study includes the evaluation of the comparability of cohorts on the basis of 
the design or analysis. Finally, the ascertainment of the outcome of interest includes the evaluation 
of the type of the assessment of the outcome of interest, length and adequacy of follow-up7. 
According to NOS a study can be awarded a maximum of one star for each numbered item within 
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Random-effect meta-analyses of proportions were used to combine data. For the purpose of the 
analysis, the denominator was represented by the number of twins per each group for the 
computation of IUD, NND, PND and rate of survivors, while the number of pregnancies for the 
assessment of PTB, presence of at least one and two survivors. Funnel plots displaying the outcome 
rate from individual studies versus their precision (1/standard error) were carried out with an 
exploratory aim. Tests for funnel plot asymmetry were not used when the total number of 
publications included for each outcome was less than ten. In this case, the power of the tests is too 
low to distinguish chance from real asymmetry
9-10
. 
Between-study heterogeneity was explored using the I
2
 statistic, which represents the percentage of 
between-study variation that is due to heterogeneity rather than chance. A value of 0% indicates no 
observed heterogeneity, whereas I
2
 values of ≥50% indicate a substantial level of heterogeneity. All 
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RESULTS   
Study selection and characteristics  
505 articles were identified, 153 were assessed with respect to their eligibility for inclusion 
(Supplementary Table 1) and 17 studies were included in the systematic review (Table 1, Figure 1). 
These 17 studies included 890 MCMA twin pregnancies; out of these 48 (96 fetuses) were affected 
by TTTS
11-27
. There was no randomized controlled trial comparing different management options 
(expectant vs laser vs cord occlusion) in MCMA twin pregnancies complicated by TTTS.  
Gestational age at diagnosis of TTTS was reported only by eight studies (22 pregnancies); TTTS 
occurred in 9.1% of cases before 16 weeks, in 18.2% between 16 and 20 weeks, in 45.5% between 
21 and 24 weeks, in 18.2% between 25 and 28 weeks and in 9.1% after 28 weeks of gestation.  
 The results of the quality assessment of the included studies using the Newcastle-Ottawa Scale 
(NOS) are presented in Table 2. Most of the included studies showed an overall good score 
regarding the selection and comparability of the study groups, and for ascertainment of the outcome 
of interest. The main weaknesses of these studies were their retrospective design, small sample size, 
heterogeneity of outcomes observed and different protocols for antenatal management of the 
pregnancies complicated by TTTS.  
 
Synthesis of the results 
No intervention 
Thirteen studies (48 fetuses-24 pregnancies) reported the outcome of MCMA twin pregnancies 
complicated by TTTS and managed expectantly (no intervention). Overall, miscarriage occurred in 
10.7% (95% CI 3.8-19.9; 4/48) of fetuses, while IUD in 24.3.4% (95% CI 13.3-37.5; 11/48). When 
assessing the risk of single and double IUD separately, single fetal loss complicated 11.0% (95% CI 
4.2-20.6; 3/48), while double IUD occurred in 11.8% (95% CI 4.7-21.6; 4/48) (Figure 2). The 
incidence of NND and PND was 13.5% (95% CI 5.8-23.8; 5/48) and 32.4% (95% CI 18.5-48.0; 
16/48), respectively. 59.9% (95% CI 45.7-71.5; 28/48) of affected cases were alive at 28 days of 
life (Figure 2). In 68.4% (95% CI 51.1-83.4;17/24) of cases, at least one twin survived to the 
neonatal period while in 46.5% (95% CI 27.1-66.5; 11/24) both twins survived. Finally, 54.0% 




Three studies (12 fetuses-6 pregnancies) reported the outcome of TTTS following laser treatment. 
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7.4% (95% CI 0.01-27.6; 1/12) and 12.5% (95% CI 0.8-35.0; 1/12), respectively. NND and PND 
occurred in 7.4% (95% CI 0.01-27.6; 1/12) and 35.9.7% (95% CI 13.1-62.8; 4/12) of cases, 
respectively. 48.2% of fetuses (95% CI 22.6-74.3; 6/12) survived to the neonatal period. (Table 3, 
Figure 2). The incidence of PTB <32 weeks of gestation was 64.9% (95% CI 28.7-93.2; 4/6).  
 
Amniodrainage 
Three studies (12cfetuses-6 pregnancies) reported the outcome of TTTS following laser treatment. 
Overall IUD, NND and PND occurred in 30.3% (95% CI 9.7-56.4; 4/12), 19.1% (95% CI 3.4-43.3; 
2/12) and 46.5% (95% CI 2.5-90.8; 6/12) of cases, respectively. 29.4% of fetuses (95% CI 2.1-70.9; 
6/14) survived to the neonatal period. 53.5% (95% CI 27.7-78.4; 6/12) of twins survived to neonatal 
period. The incidence of PTB <32 weeks of gestation was 78.1% (95% CI 44.1.3-98.4; 5/6) (Table 
3, Figure 2).  
 
Cord occlusion 
Finally, only three studies (6 fetuses-3 pregnancies) explored the outcome of non-anomalous 
MCMA pregnancies complicated by TTTS treated by cord occlusion of one twin. In view of the 
very small number of included cases and even smaller number of events, the results reported in this 
review are affected by the low power of the analysis and may not reflect the actual incidence of the 
explored outcomes in pregnancies undergoing cord occlusion. Furthermore, it was not specified 
whether all cases had cord transection after occlusion. Miscarriage occurred in 19.2% (95% CI 0.9-
52.6); 1/6), while there was no IUD or NND of the surviving twin. Overall, 80.8% (95% CI 47.4-
99.1; 5/6) of fetuses survived to the neonatal period, while the incidence of PTB <32 weeks was 
50.0% (95% CI 17.2-82.8; 3/6) (Table 3, Figure 2).  
 
Sub-group analysis: TTTS diagnosed 24 weeks of gestation 
The results of the sub-group analysis of cases complicated by TTTS diagnosed at or before 24 
weeks of gestation are shown in Supplementary Table 2. In cases not undergoing intervention, the 
incidence of IUD was 39.5% (95% CI 9.1-75.5; 6/16). There was no single fetal loss, while the 
incidence of double IUD was 21.2% (95% CI 6.3-41.8; 3/16). Finally, PND occurred in 50.8% 
(95% CI 16.9-84.3; 8/16). Two studies (6 fetuses) explored the outcome of TTTS occurring < 24 
weeks of gestation treated with laser therapy. IUD occurred in 50.0% (95% CI 16.3-83.7; 3/6). 
Single and double IUD occurred in 20.4% (95% CI 0.3-51.5; 1/6) and 21.4% (95% CI 11.8-56.4; 
1/6), respectively. The incidence of NND and PND was 17.3% (95% CI 0.3-51.5; 1/6) and 68.8% 
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cases undergoing amniodrainage because we could extract the data for the outcomes observed in the 
present systematic review only from one study
21
. Finally, three studies explored the outcome of 
MCMA pregnancies affected by TTTS undergoing cord occlusion. The rate of miscarriage was 
26.2% (95% CI 0.03-7.9; 1/6), while there were no cases of IUD and NND, although only 6 
pregnancies were included in the analysis. Inter-group comparison among the three management 
options could not be reliably computed in view of the very small number of studies reporting the 
three management options, which precluded a comprehensive assessment of the strength of 
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DISCUSSION  
Main findings  
The findings from this systematic review show that, in MCMA twin pregnancies complicated by 
TTTS, IUD occurred in 24.3% of cases with no fetal treatment and in 27.4%  and 30.3% of those 
undergoing laser and amniodrainage, while there was no loss of the surviving twin in cases 
undergoing cord occlusion. The large majority of fetal losses were double IUD. Finally, in view of 
the very small number of included studies and lack of direct comparison, it was not possible to 
extrapolate objective evidence on the optimal type of prenatal treatment in these complex 
pregnancies.  
 
Strengths and limitations  
Thorough literature search aimed at identifying all the possible relevant studies, multitude of 
outcomes explored and stratification of the analysis according to the type of prenatal management 
are the main strengths of the present systematic review. The small number of cases in some of the 
included studies, their retrospective non-randomized design, lack of standardized criteria for the 
antenatal management and surveillance of MCMA twin pregnancies complicated by TTTS 
represent the major limitations of this systematic review. Furthermore, the large majority of the 
included studies did not report the comparison between the different management options, thus 
making the different populations potentially unbalanced for the main determinants of outcome in 
TTTS, such as gestational age at occurrence or severity of the disease. Other major limitations of 
the present systematic review were the lack of stratification of the results according to the 




Interpretation of findings and comparison with other published evidence.  
The findings from this review confirm the high rate of perinatal mortality observed in MCMA 
pregnancies affected by TTTS. Prenatal diagnosis of TTTS in MCMA gestations is challenging 
since the polyhydramnios-oligohydramnios sequence cannot be detected and diagnosis should be 
based on other signs, including polyhydramnios, discordance in bladder size, cardiomegaly and 
abnormal Doppler flow patterns in either twin
15
. Conversely, the peculiar anastomotic pattern of 
MCMA twin placentas, with larger placental anastomoses compared to MCDA pregnancies, may 
predispose to acute TTTS leading to sudden fetal death, thus explaining the high rate of perinatal 
mortality observed in the present systematic review. This may explain the relatively large number 
of cases not undergoing intervention included in the present review. In view of the lack of direct 
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original publications and the very small number of included cases, it was not possible to extrapolate 
an objective evidence on the optimal type of management of MCMA twins affected by TTTS. 
Therefore, perinatal management of these pregnancies should be individualized according to 
gestational age at occurrence, severity of the disease, legal regulations and parents’ wishes.  
 
Clinical and research implications  
The optimal type of monitoring of MCMA twin pregnancies is yet to be ascertained
31
. There are no 
randomized controlled trials comparing the different management protocols in MCMA twin 
pregnancies. There is also wide variation in practice with regards to the type and frequency of fetal 
monitoring and timing at initiation of fetal surveillance among the recently published studies
2
. 
Fortnightly ultrasound assessment and prompt referral of cases affected by TTTS to centers with 
high expertise in fetal surgery has led to a significant reduction in perinatal mortality in MCDA 
twin pregnancies
32,33
. Laser coagulation of placental anastomoses is the gold standard for managing 
MCDA twin pregnancies affected by TTTS before third trimester. In the present review, the 
survival rate of MCMA twins undergoing laser was lower compared to what reported for MCDA 
pregnancies (30% vs 38%). The relatively higher risk of IUD in pregnancies undergoing laser 
therapy might be partially explained by the fact that TTTS in MCMA twins occurs more acutely 
compared to MCDA pregnancies. Furthermore, although often performed with technical success, 
laser treatment in MCMA pregnancies can be technically challenging. High incidence of proximate 
cord insertions and the large-diameter of artero-arterial anastomoses can make photocoagulation 
difficult and this may represent an additional source of bias among the included cases. Finally, it is 
also likely that the high incidence of perinatal mortality of MCMA pregnancies treated with laser 
observed in the present review might have been the result of inclusion of mainly cases with 
advanced cardiovascular compromise, considering the fact that TTTS can be difficult to diagnose in 
MCMA pregnancies.  
 
In MCDA twins, amnioreduction does not represent the primary treatment for TTTS as laser 
therapy has been proved to be associated with a better perinatal outcome
5
. However, 
amnioreduction may be indicated especially in pregnancies presenting with TTTS >26 weeks of 
gestation with symptoms of to uterine overdistension debilitating symptoms (eg, significant 
respiratory distress and/or uterine contractions) in order to relieve maternal symptoms. In the 
present review, amniodrainage was affected by a very high incidence of PTB, without a 
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The very small number of include cases and even smaller number of events did not allow to draw 
any objective conclusion on the role of cord occlusion in the surgical management of MCMA twins 
pregnancies affected by TTTS. Cord occlusion may represent an alternative in those pregnancies 
presenting with signs impending fetal demise of one twin especially when far from viability, but 
may be not ethically acceptable for some parents. In case cord occlusion is performed, cord 
transection after occlusion has been reported a feasible technique potentially able to prevent the 





MCMA twin pregnancies complicated by TTTS are at high risk of perinatal mortality and PTB. In 
view of the small number of included cases, heterogeneity in gestational age at treatment, disease 
severity and study populations, the present systematic review could not elucidate the optimal 
treatment for MCMA twins affected by TTTS. Further large multicenter studies sharing objective 
protocols for antenatal surveillance, indication for fetal surgery and post-natal follow-up are needed 
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Figure legend 
Figure 1. Systematic review flowchart. 
Figure 2. Forest plots displaying the pooled proportions of the different outcomes observed in the 
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Table 1. General characteristics of the included studies 
 
Author Year Country Study design Period analysed 








2018 United Kingdom Retrospective 2000-2013 18.8 (2.8) 85 3 
Madsen
12 
2018 Denmark Prospective 2004-2013 NS 61 1 
Anselem














Retrospective 2000-2012 II-III trimester 50 9 
Murata
16 2013 Japan Retrospective 2001-2011 NS 38 1 
Suzuki
17 
2013 Japan Retrospective NS NS 18 2 
Morikawa
18 
2012 Japan Retrospective 2002-2009 NS 101 4 
Baxi
19 
2010 United States Retrospective 2001-2009 NS 25 1 
Hack
20 
2009 Netherlands Retrospective 2000-2007 NS 98 6 
Schaap
21 
2006 Netherlands Case report NS NS 1 1 
Cordero
22 
2006 United States Retrospective 1990-2005 28 (2.8) 36 3 
DeFalco
23 
2006 United States Retrospective 1991-2001 NS 23 1 
Gallot
24 2005 France Case report NS 16 1 1 
Heyborne
25 2005 United states Retrospective 1993-2003 NS 96 3 
Demaria
26 
2004 France Retrospective 1993-2001 NS 19 2 
Sau
27 
2003 Singapore Retrospective 1994-2000 NS 7 1 
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Table 2. Quality assessment of the included studies according to Newcastle-Ottawa Scale (NOS) 
for cohort studies; a study can be awarded a maximum of one star for each numbered item within 
the Selection and Outcome categories. A maximum of two stars can be given for Comparability. 
 
Author Year Selection Comparability Outcome 
Glinianaia
11 2018   
Madsen
12 
2018   
Anselem
13 2015   
Van Mieghem
14 
2014   
Peeters
15 2014   
Murata
16 2013   
Suzuki
17 
2013   
Morikawa
18 2012   
Baxi
19 
2010   
Hack
20 
2009   
Schaap
21 2006   
Cordero
22 
2006   
DeFalco
23 2006   
Gallot
24 
2005   
Heyborne
25 
2005   
Demaria
26 2004   
Sau
27 
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Table 3. Pooled proportions for the outcomes observed in the present systematic review in 
monochorionic mono-amniotic (MCMA) twin pregnancies complicated by twin-to-twin transfusion 
syndrome (TTTS). 
 











Miscarriage (overall) 13 4/48 8.33 (2.3-20.0) 10.4 10.74 (3.8-19.9) 
IUD (overall) 13 11/48 22.92 (12.0-37.3) 11.8 24.34 (13.3-37.5) 
Single IUD 13 3/48 6.25 (1.3-17.2) 0 11.03 (4.2-20.6) 
Double IUD
*
 13 4/48 8.33 (2.3-20.0) 0 11.78 (4.7-21.6) 
NND 13 5/48 10.42 (3.5-22.7) 0 13.52 (5.8-23.8) 
PND 13 16/48 33.33 (20.4-48.4) 27.7 32.36 (18.5-48.0) 
Survivors 13 28/48 58.33 (43.2-72.4) 49.3 59.85 (45.7-71.5) 
At least one survivor
c
 13 17/24 70.83 (48.9-87.4) 0 68.39 (51.1-83.4) 
Two survivors
c
 13 11/24 45.83 (25.6-67.2) 20.8 46.54 (27.1-66.5) 
PTB < 32 weeks 10 9/16 56.25 (29.9-80.2) 48.6 54.0 (24.8-81.8) 
Laser therapy 
Miscarriage (overall) 2 2/12 16.67 (2.1-48.4) 0 19.63 (3.5-44.5) 
IUD (overall) 2 3/12 25.00 (5.5-57.2) 0 27.39 (7.6-53.7) 
Single IUD 2 1/12 8.33 (0.2-38.5) 69 7.36 (0.01-27.6) 
Double IUD
*
 2 1/12 8.33 (0.2-38.5) 0 12.46 (0.8-35.0) 
NND 2 1/12 8.33 (0.2-38.5) 69 7.36 (0.01-27.6) 
PND 2 4/12 33.33 (9.9-65.1) 79 35.93 (13.1-62.8) 
Survivors 2 6/12 50.0 (21.1-78.9) 61.8  48.23 (22.6-74.3) 
At least one survivor
c
 2 3/6 50.0 (11.8-88.2) 7 47.30 (12.5-83.7) 
Two survivors
c
 2 3/6 50.0 (11.8-88.2) 7 47.30 (12.5-83.7) 
PTB < 32 weeks 2 4/6 66.67 (22.3-95.7) 0 64.86 (28.7-93.2) 
Ammniodrainage 
Miscarriage (overall) 3 0/12 0 (0-26.5) 0 0 (0-22.5) 
IUD (overall) 3 4/12 33.33 (9.9-65.1) 67.4 30.31 (9.7-56.4) 
Single IUD 3 0/12 0 (0-26.5) 0 0 (0-22.5) 
Double IUD
*
 3 2/12 16.67 (2.1-48.4) 0 18.29 (3.0-42.3) 
NND 3 2/12 16.67 (2.1-48.4) 0 19.06 (3.4-43.3) 
PND 3 6/12 50.0 (21.1-78.9) 74.8 46.46 (2.5-90.8) 
Survivors 3 6/12 50.0 (21.1-78.9) 74.8 53.54 (27.7-78.4) 
At least one survivor
c
 3 4/6 66.67 (22.3-95.7) 20.3 68.75 (29.2-96.6) 
Two survivors
c
 3 2/6 33.33 (4.3-77.7) 68 33.92 (6.8-68.9) 




Miscarriage (overall) 3 1/6 16.67 (0.4-64.1) 50.7 19.18 (0.9-52.6) 
IUD (overall) 3 0/6 0 (0-39.0) 0 0 (0-37.0) 
NND 3 0/6 0 (0-39.0) 0 0 (0-37.0) 
PND 3 0/6 0 (0-39.0) 0 0 (0-37.0) 
Survivors 3 5/6 83.33 (35.9-99.6) 50.7 80.82 (47.4-99.1) 
PTB < 32 weeks 3 3/6 60.0 (14.7-94.7) 0 50.00 (17.2-82.8) 
 
a: includes cases managed expectantly or those in which in utero therapy could not be performed. 
b: The fetus undergoing cord occlusion was not considered for the computation of the different observed outcomes.  
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